Meyka AI API is live for developers.Start building.
Advertisement
Athenex, Inc.

Athenex, Inc. (ATNX) Stock Overview

Explore Athenex, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ATNXNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.20
$0.00(0.00%)
U.S. Market opens in 47h 37m
Advertisement

Athenex, Inc. (ATNX)

Meyka AI Score

Z

Key Financials

Market Cap2.3M
P/E Ratio-0.01
EPS (TTM)$-10.45
ROE0.22%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ATNX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Athenex, Inc. (ATNX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 2.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-23.39%
3-Month Change
-84.38%
6-Month Change
-93.44%
Year-to-Date (YTD) Change
-94.16%
1-Year Change
-98.12%
3-Year Change
-99.92%
5-Year Change
-99.95%
All-Time (Max) Change
-99.92%

Contact Information

716 427 2950
Conventus Building, Buffalo, NY, 14203

Company Facts

2,690 Employees
IPO DateJun 14, 2017
CountryUS

Frequently Asked Questions